Browse the evidence

SGLT2 inhibition (canagliflozin) reduces adiposity and activates lipolysis exclusively through FGF21-dependent mechanisms, while its effects on lipid oxidation, ketogenesis, and hepatic steatosis reduction are FGF21-independent.

SGLT2 inhibitors reduce body fat by triggering a hormonal signal (FGF21) that activates fat burning (lipolysis). This process is distinct from simple calorie restriction and requires the presence of FGF21 to effectively reduce fat mass.

Pro-inflammatory cytokines IL-1beta and TNF-alpha are somnogenic; their expression increases with waking activity and sleep deprivation, and they promote non-rapid-eye movement (NREM) sleep and slow-wave activity (SWA).

Prioritize sleep hygiene not just for rest, but to regulate inflammation. Chronic wakefulness or poor sleep increases pro-inflammatory cytokines like IL-1beta and TNF-alpha, which can disrupt sleep architecture and overall health. Managing inflammation through lifestyle may improve sleep, and good sleep helps manage inflammation.

The NLRP3 inflammasome is a critical mediator of sleep regulation; its activation leads to the production of IL-1beta and IL-18, which promote NREM sleep and slow-wave activity.

Understanding that sleep loss activates the NLRP3 inflammasome suggests that chronic sleep deprivation may fuel a cycle of inflammation. Breaking this cycle by improving sleep may reduce inflammasome activity.

Circadian rhythm disruption is associated with increased morbidity risk for inflammatory diseases, including cardiovascular disease, cancer, and metabolic disease.

Maintaining a regular sleep-wake cycle is crucial for long-term health, as disrupting your circadian rhythm increases the risk of inflammatory diseases like heart disease and cancer.

Mitochondrial dysfunction and ER stress are key mechanistic drivers of insulin resistance, primarily through the activation of inflammatory pathways and impaired insulin signaling.

Insulin resistance is driven by cellular stress in mitochondria and the ER, often caused by chronic overnutrition. Managing metabolic health involves reducing this cellular stress through balanced nutrition and activity, rather than just focusing on weight.

Fasting-induced elevation of the myokine FGF21 is required for starvation-mediated muscle atrophy and weakness; its absence preserves muscle mass and force during caloric restriction.

If you are fasting or in a caloric deficit, your body actively uses the hormone FGF21 to break down muscle. This paper suggests that blocking this specific hormonal signal could theoretically preserve muscle mass even without food. While this is a mouse study, it highlights that muscle loss isn't just 'inevitable' during fasting but is driven by specific biological switches.

FGF21 promotes muscle atrophy by increasing mitophagy flux via the protein Bnip3, rather than through the ubiquitin-proteasome system (UPS).

This paper identifies Bnip3 and mitophagy (mitochondrial recycling) as the specific cellular mechanism FGF21 uses to break down muscle during starvation. Blocking this specific pathway, rather than just general protein breakdown, might be key to preserving muscle during stress.

GIP receptor (GIPR) antagonism prevents diet-induced obesity and reduces fat mass in mice and non-human primates, independent of pancreatic beta-cell GIPR activity.

Blocking the GIP receptor appears to be a powerful strategy for weight loss in preclinical models, working by reducing food intake and increasing fat burning (lipid oxidation). This effect is independent of how the pancreas handles insulin, suggesting a direct metabolic benefit. When combined with existing GLP-1 drugs (like semaglutide or liraglutide), weight loss is significantly enhanced, suggesting these mechanisms can be stacked for greater efficacy.

Sleep irregularity is associated with increased perceived stress and depressive symptoms, which may serve as additional mechanisms linking irregular sleep to cardiometabolic disease.

Recognize that mental health and sleep consistency are linked. If you are experiencing high stress or depressive symptoms, improving your sleep regularity (consistent bed/wake times) may help alleviate these symptoms and reduce your long-term risk of cardiovascular disease.

Tirzepatide improves systemic insulin sensitivity in obese mice through a weight-independent mechanism mediated by GIP receptor (GIPR) agonism, which enhances glucose disposal in white adipose tissue and upregulates BCAA catabolism in brown adipose tissue.

Tirzepatide improves how your body handles sugar through two paths: losing weight and directly activating receptors in your fat tissue to burn glucose and amino acids more efficiently. This dual action means it can improve blood sugar control even if weight loss is modest.

Activation of PPARγ by thiazolidinediones (TZDs) like pioglitazone and rosiglitazone improves insulin sensitivity and glucose homeostasis, primarily by promoting fatty acid storage in adipose tissue and enhancing glucose uptake in skeletal muscle.

TZDs like pioglitazone activate PPARγ to help your body handle sugar better. They work by moving fat storage to your皮下 fat (subcutaneous) rather than your liver and muscles, which reduces insulin resistance. This improves blood sugar control but may lead to weight gain.

Insulin resistance promotes atherosclerosis through impaired insulin signaling (specifically reduced PI-3 kinase activation) which decreases nitric oxide production, leading to endothelial dysfunction and accelerated plaque progression, independent of hyperglycemia.

If you have insulin resistance or obesity, your cardiovascular risk is elevated even if your blood sugar is normal. Focus on improving insulin sensitivity through lifestyle changes rather than just monitoring glucose levels, as high insulin itself drives arterial damage.

Chronic hyperglycemia accelerates atherosclerosis through three distinct mechanisms: formation of advanced glycation end products (AGEs) that modify LDL, increased oxidative stress reducing nitric oxide, and pathologic activation of Protein Kinase C (PKC).

High blood sugar damages arteries through multiple pathways, including modifying LDL particles and increasing oxidative stress. Managing glucose is important, but it is only one part of the equation; insulin resistance and lipid management are equally critical.

Inflammation is involved in every step of the atherosclerotic process, from initial lipid retention to plaque destabilization, mediated by both innate (macrophages, TLRs) and adaptive (T cells, B cells) immune responses.

Inflammation drives every stage of heart disease, from the initial buildup of plaque to the rupture that causes heart attacks. Managing inflammation through lifestyle and potentially targeted therapies is crucial for preventing cardiovascular events, not just lowering cholesterol.

Female gender is a significant independent risk factor for poor sleep quality during pandemic lockdowns.

Women may be biologically more vulnerable to sleep disruption during high-stress periods. If you are female, be extra vigilant about sleep hygiene and stress management, as your baseline risk for sleep issues is higher than men's in similar circumstances.

Intranasal insulin administration improves memory and cognitive function in patients with mild cognitive impairment (MCI) and early Alzheimer's disease, particularly in non-ApoE4 carriers and women.

If you have early memory issues or MCI, ask your doctor about intranasal insulin. It is a nasal spray that may help improve memory and attention without causing low blood sugar. This treatment seems to work best for women and those who do not carry the ApoE4 gene variant. It is not a cure, but it may help manage symptoms.

Peripheral metabolic dysregulation (obesity, diabetes) leads to brain insulin resistance and Alzheimer's pathology through BBB permeabilization, neuroinflammation, and AGE-RAGE signaling.

Managing your weight, blood sugar, and metabolic health is crucial for brain health. Obesity and diabetes increase the risk of Alzheimer's by causing inflammation and insulin resistance in the brain. Focus on a healthy diet and exercise to protect your brain.

Adiposity (body fat percentage) does not significantly modify the acute or chronic appetite and energy intake responses to exercise, meaning exercise is equally effective for appetite regulation in lean and overweight/obese individuals.

Your body weight does not determine how well exercise works for regulating your appetite. Whether you are lean or have overweight/obesity, exercise will similarly suppress your appetite temporarily and not trigger compensatory overeating. This makes exercise a universally applicable tool for energy balance.

Low energy availability causes a 'sick euthyroid' profile with decreased T3 and increased reverse T3, reducing energy expenditure as an adaptive response.

Low energy intake can lower your T3 levels as a way to conserve energy. This is a normal adaptation, not necessarily a thyroid disease. Focus on eating enough to support your activity level, which should normalize your thyroid hormones.

During the luteal phase of the menstrual cycle, healthy women exhibit significantly reduced plasma levels of amino acids and lipids, indicating an anabolic state driven by progesterone that increases metabolic vulnerability to conditions like PMS and PMDD.

If you experience PMS or PMDD symptoms, your body is likely in a metabolically demanding 'anabolic' state during the luteal phase (post-ovulation) where amino acids and lipids are being utilized for tissue preparation. This creates a window of vulnerability. While this paper does not prescribe a specific diet, it suggests that ensuring sufficient protein and nutrient intake during this phase may help support the body's increased metabolic demands and potentially mitigate symptoms.

Exenatide (2 mg once weekly) significantly reduces alcohol cue reactivity in the ventral striatum and septal area in patients with Alcohol Use Disorder, but does not significantly reduce heavy drinking days in the general AUD population.

Exenatide, a weekly injection used for diabetes and obesity, changes how the brain responds to alcohol cues in addicted individuals, potentially reducing the 'pull' of drinking triggers. However, this neurobiological change did not automatically lead to fewer heavy drinking days for most patients in this study. It suggests that while the drug modifies reward processing, it may not be sufficient as a standalone treatment for reducing actual alcohol consumption in the general AUD population without additional behavioral support.

In obesity, elevated saturated fatty acids and proinflammatory cytokines activate JNK and IKK kinases, which phosphorylate insulin receptor substrate (IRS) on inhibitory serine residues, thereby blocking PI3K/Akt signaling and causing insulin resistance.

If you have excess body fat, your cells are likely resisting insulin due to inflammatory signaling triggered by fats and cytokines. This isn't permanent damage; it's a reversible signaling block. Reducing caloric excess and saturated fat intake can lower the metabolic stress that triggers this inflammatory kinase activity, potentially restoring insulin sensitivity.

NOX2-derived cytosolic ROS production is required for exercise-stimulated glucose uptake and GLUT4 translocation in skeletal muscle.

During moderate-intensity exercise, your body produces specific reactive oxygen species (ROS) via the NOX2 enzyme to signal muscles to take up glucose. This is a necessary signaling event, not just damage. While you don't need to 'increase' ROS intentionally, understanding that some oxidative stress is functional helps explain why extreme antioxidant supplementation might interfere with metabolic adaptations to exercise.

Cold exposure and beta-3 adrenergic agonists are primary physiological and pharmacological agents that induce the browning of white adipose tissue.

Exposing your body to cold temperatures (like cold showers or cool rooms) stimulates your sympathetic nervous system, which can trigger white fat to turn into energy-burning beige fat. Pharmacological beta-3 agonists do this too, but lifestyle cold exposure is the natural, side-effect-free method.